NCT05426902View on ClinicalTrials.gov

Utilizing Qualitative and Quantitative Methods to Understand a New Model of Type 1 and 2 Systemic Lupus Erythematosus (SLE)

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 3, 2022

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Systemic Lupus Erythematosus
Interventions
BEHAVIORAL

SLE@Duke

SLE@Duke is a set of tools to implement the Type 1 \& 2 SLE Model in a clinical setting. The model includes an Electronic Medical Record (EMR) note template, patient-reported outcome measure, and training on how to discuss Type 1 \& 2 SLE.

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

Duke University

OTHER